TEC
GH icon

Tiger Eye Capital’s Guardant Health GH Stock Holding History

Tiger Eye Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-42,955
Closed -$2.74M – 48
2019
Q3 		$2.74M Sell
42,955
-32,490
-43% -$2.86M 0.72% 19
2019
Q2 		$6.51M Buy
75,445
+49,945
+196% +$3.81M 1.36% 20
2019
Q1 		$1.96M Buy
+25,500
New +$1.41M 0.48% 27

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VS
VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Tiger Eye Capital's GH Position: Q4 2019 in Review

Tiger Eye Capital sold out of Guardant Health (GH) in Q4 2019, closing a stake of 42,955 shares — an estimated $2.74M sold.

Tiger Eye Capital first reported a position in GH in Q1 2019 and held it in 3 quarters. The position peaked at $6.51M in Q2 2019. 268 funds tracked by Wall St. Rank hold GH as of Q4 2019.

  • Tiger Eye Capital reported no remaining Guardant Health position as of Q4 2019 after selling out during the quarter.
  • Tiger Eye Capital sold 42,955 Guardant Health shares in Q4 2019, an estimated $2.74M.
  • Tiger Eye Capital first reported a position in Guardant Health in Q1 2019 and held it in 3 quarters.
  • Tiger Eye Capital's Guardant Health position peaked at $6.51M in Q2 2019.
  • 268 funds tracked by Wall St. Rank held Guardant Health as of Q4 2019.

Based on Tiger Eye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.